In conclusion, the activated PBX2‐PRMT1‐SWI/SNF‐IGF2BP2 signaling pathway likely plays a critical role in the progression and prognosis of HNSCC (Figure 7L). This evidence concerns the gene PBX2 and head and neck squamous cell carcinoma.